Intrommune Therapeutics to Present at New York Venture Capital Association 2016 Health & Bio Technology Summit New York, Feb. 22, 2016 (GLOBE NEWSWIRE) -- Intrommune Therapeutics,  a specialty biopharmaceutical company developing a patient-friendly platform for the treatment of food allergies, today...

Intrommune Therapeutics to Participate in Meetings with the Investment Community During the 34th Annual JP Morgan Healthcare Conference, January 11-14, 2016 New York, NY, Dec. 29, 2015 (GLOBE NEWSWIRE) -- Intrommune Therapeutics (“Intrommune”), a New York City-based biotechnology company developing patient-friendly therapies for food allergy, today...